OUTBRAIN INC (OB)

US69002R1032 - Common Stock

4.09  +0.03 (+0.74%)

After market: 4.09 0 (0%)

Fundamental Rating

3

Taking everything into account, OB scores 3 out of 10 in our fundamental rating. OB was compared to 68 industry peers in the Interactive Media & Services industry. OB has a bad profitability rating. Also its financial health evaluation is rather negative. OB is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

OB had negative earnings in the past year.
In the past year OB had a positive cash flow from operations.
In multiple years OB reported negative net income over the last 5 years.
Each year in the past 5 years OB had a positive operating cash flow.

1.2 Ratios

OB has a Return On Assets of 1.54%. This is in the better half of the industry: OB outperforms 64.18% of its industry peers.
OB has a Return On Equity of 4.60%. This is in the better half of the industry: OB outperforms 68.66% of its industry peers.
Industry RankSector Rank
ROA 1.54%
ROE 4.6%
ROIC N/A
ROA(3y)-0.08%
ROA(5y)-1.4%
ROE(3y)-0.81%
ROE(5y)-5.7%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of OB (1.10%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of OB has grown nicely.
OB has a Gross Margin of 19.75%. This is amonst the worse of the industry: OB underperforms 86.57% of its industry peers.
In the last couple of years the Gross Margin of OB has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1.1%
GM 19.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y70.29%
PM growth 5YN/A
GM growth 3Y-2.83%
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

OB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OB has been reduced compared to 1 year ago.
The debt/assets ratio for OB has been reduced compared to a year ago.

2.2 Solvency

OB has an Altman-Z score of 1.47. This is a bad value and indicates that OB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of OB (1.47) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.53 indicates that OB is somewhat dependend on debt financing.
OB has a Debt to Equity ratio of 0.53. This is in the lower half of the industry: OB underperforms 74.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACCN/A
WACC8.69%

2.3 Liquidity

OB has a Current Ratio of 1.35. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
OB's Current ratio of 1.35 is on the low side compared to the rest of the industry. OB is outperformed by 73.13% of its industry peers.
A Quick Ratio of 1.35 indicates that OB should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.35, OB is not doing good in the industry: 73.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.72% over the past year.
OB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 81.64% yearly.
OB shows a decrease in Revenue. In the last year, the revenue decreased by -5.67%.
OB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)83.72%
EPS 3Y81.64%
EPS 5YN/A
EPS growth Q2Q164.29%
Revenue 1Y (TTM)-5.67%
Revenue growth 3Y6.85%
Revenue growth 5YN/A
Revenue growth Q2Q-3.79%

3.2 Future

The Earnings Per Share is expected to grow by 61.81% on average over the next years. This is a very strong growth
Based on estimates for the next years, OB will show a small growth in Revenue. The Revenue will grow by 4.03% on average per year.
EPS Next Y-1.53%
EPS Next 2Y127.4%
EPS Next 3Y100.58%
EPS Next 5Y61.81%
Revenue Next Year0.99%
Revenue Next 2Y4.63%
Revenue Next 3Y4.51%
Revenue Next 5Y4.03%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

OB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

OB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OB is cheaper than 92.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.8

4.3 Compensation for Growth

OB's earnings are expected to grow with 100.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y127.4%
EPS Next 3Y100.58%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTBRAIN INC

NASDAQ:OB (4/19/2024, 7:07:46 PM)

After market: 4.09 0 (0%)

4.09

+0.03 (+0.74%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap200.61M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.54%
ROE 4.6%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 1.1%
GM 19.75%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)83.72%
EPS 3Y81.64%
EPS 5Y
EPS growth Q2Q
EPS Next Y-1.53%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.67%
Revenue growth 3Y6.85%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y